Cara Therapeutics reported $-23845000 in EBIT for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acadia Pharmaceuticals ACAD:US USD -30866000 2.78M
Acelrx Pharmaceuticals ACRX:US USD -6632000 2.04M
Cara Therapeutics CARA:US USD -23845000 19.37M
Chugai Pharma 4519:JP JPY 149.47B 52.59B
Endo International Ordinary Shares ENDP:US USD 55.64M 26.07M
Halozyme Therapeutics HALO:US USD 83.69M 49.63M
Horizon Pharma HZNP:US USD 188.16M 41.16M
Johnson & Johnson JNJ:US USD 6.27B 572M
Neurocrine Biosciences NBIX:US USD 87.8M 33.1M
Pacira Pharmaceuticals PCRX:US USD 21.78M 8.6M
Pain Therapeutics PTIE:US USD -21345000 1.43M
Pfizer PFE:US USD 5.81B 3.89B
Revance Therapeutics RVNC:US USD -77484000 19.64M
Teva Pharmaceutical Industries TEVA:US USD 740M 6M